Li Ling-Jun, Aris Izzuddin M, Su Lin Lin, Chong Yap Seng, Wong Tien Yin, Tan Kok Hian, Wang Jie Jin
Division of O&GKK Women's and Children's Hospital, Singapore, Singapore
O&G ACPDuke-NUS Graduate Medical School, Singapore, Singapore.
Endocr Connect. 2018 Mar;7(3):433-442. doi: 10.1530/EC-17-0359. Epub 2018 Feb 14.
The cumulative effect of gestational diabetes mellitus (GDM) and hypertensive disorders of pregnancy (HDP) on postpartum cardio-metabolic diseases is equivocal. We aimed to assess the associations of GDM and HDP's individual and synergic contribution to risks of postpartum cardio-metabolic diseases (metabolic syndrome (MetS), abnormal glucose metabolism and hypertension (HTN)).
Of participants from a Singapore birth cohort, 276 mothers attending the 5-year postpartum visit were included in this study. During this visit, we collected mothers' history of GDM and HDP in all live births in a chronicle sequence and assessed the cardio-metabolic risks based on blood pressure, anthropometry and a panel of serum biomarkers. We diagnosed MetS, abnormal glucose metabolism and HTN according to Adult Treatment Panel III 2000 and World Health Organization guidelines.
Of 276 mothers, 157 (56.9%) had histories of GDM while 23 (8.3%) had histories of HDP. After full adjustment, we found associations of GDM episodes with postpartum abnormal glucose metabolism (single episode: relative risk (RR) 2.9 (95% CI: 1.7, 4.8); recurrent episodes (≥2): RR = 3.8 (2.1-6.8)). Also, we found association between histories of HDP and HTN (RR = 3.6 (1.5, 8.6)). Having either (RR 2.6 (1.7-3.9)) or both gestational complications (RR 2.7 (1.6-4.9)) was associated with similar risk of postpartum cardio-metabolic disease.
Mothers with GDM or HDP had a threefold increased risk of postpartum abnormal glucose metabolism or HTN, respectively. Having both GDM and HDP during past pregnancies was not associated with additional risk of postpartum cardio-metabolic diseases beyond that associated with either complication alone.
妊娠期糖尿病(GDM)和妊娠高血压疾病(HDP)对产后心血管代谢疾病的累积影响尚不明确。我们旨在评估GDM和HDP对产后心血管代谢疾病(代谢综合征(MetS)、糖代谢异常和高血压(HTN))风险的个体及协同作用。
本研究纳入了新加坡一个出生队列中的参与者,其中276名母亲参加了产后5年随访。在此次随访中,我们按时间顺序收集了母亲在所有活产中的GDM和HDP病史,并根据血压、人体测量学和一组血清生物标志物评估心血管代谢风险。我们根据2000年成人治疗小组III和世界卫生组织指南诊断MetS、糖代谢异常和HTN。
在276名母亲中,157名(56.9%)有GDM病史,23名(8.3%)有HDP病史。经过全面调整后,我们发现GDM发作次数与产后糖代谢异常有关(单次发作:相对风险(RR)2.9(95%置信区间:1.7,4.8);复发发作(≥2次):RR = 3.8(2.1 - 6.8))。此外,我们发现HDP病史与HTN之间存在关联(RR = 3.6(1.5,8.6))。患有其中一种(RR 2.6(1.7 - 3.9))或两种妊娠并发症(RR 2.7(1.6 - 4.9))与产后心血管代谢疾病的风险相似。
患有GDM或HDP的母亲产后糖代谢异常或HTN的风险分别增加了两倍。既往妊娠同时患有GDM和HDP与产后心血管代谢疾病的额外风险无关,其风险不超过单独一种并发症所带来的风险。